Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons.

Pietras EM, Lakshminarasimhan R, Techner JM, Fong S, Flach J, Binnewies M, Passegué E.

J Exp Med. 2014 Feb 10;211(2):245-62. doi: 10.1084/jem.20131043. Epub 2014 Feb 3.

2.

Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion.

Sato T, Onai N, Yoshihara H, Arai F, Suda T, Ohteki T.

Nat Med. 2009 Jun;15(6):696-700. doi: 10.1038/nm.1973.

PMID:
19483695
3.

Interferon-γ impairs proliferation of hematopoietic stem cells in mice.

de Bruin AM, Demirel Ö, Hooibrink B, Brandts CH, Nolte MA.

Blood. 2013 May 2;121(18):3578-85. doi: 10.1182/blood-2012-05-432906. Epub 2013 Mar 13.

4.

A non-redundant function of cyclin E1 in hematopoietic stem cells.

Campaner S, Viale A, De Fazio S, Doni M, De Franco F, D'Artista L, Sardella D, Pelicci PG, Amati B.

Cell Cycle. 2013 Dec 1;12(23):3663-72. doi: 10.4161/cc.26584. Epub 2013 Sep 25.

5.

Necdin, a p53 target gene, regulates the quiescence and response to genotoxic stress of hematopoietic stem/progenitor cells.

Asai T, Liu Y, Di Giandomenico S, Bae N, Ndiaye-Lobry D, Deblasio A, Menendez S, Antipin Y, Reva B, Wevrick R, Nimer SD.

Blood. 2012 Aug 23;120(8):1601-12. doi: 10.1182/blood-2011-11-393983. Epub 2012 Jul 9.

6.

p53 regulates hematopoietic stem cell quiescence.

Liu Y, Elf SE, Miyata Y, Sashida G, Liu Y, Huang G, Di Giandomenico S, Lee JM, Deblasio A, Menendez S, Antipin J, Reva B, Koff A, Nimer SD.

Cell Stem Cell. 2009 Jan 9;4(1):37-48. doi: 10.1016/j.stem.2008.11.006.

7.

Irgm1 protects hematopoietic stem cells by negative regulation of IFN signaling.

King KY, Baldridge MT, Weksberg DC, Chambers SM, Lukov GL, Wu S, Boles NC, Jung SY, Qin J, Liu D, Songyang Z, Eissa NT, Taylor GA, Goodell MA.

Blood. 2011 Aug 11;118(6):1525-33. doi: 10.1182/blood-2011-01-328682. Epub 2011 Jun 1.

8.

Repression of p53-target gene Bbc3/PUMA by MYSM1 is essential for the survival of hematopoietic multipotent progenitors and contributes to stem cell maintenance.

Belle JI, Petrov JC, Langlais D, Robert F, Cencic R, Shen S, Pelletier J, Gros P, Nijnik A.

Cell Death Differ. 2016 May;23(5):759-75. doi: 10.1038/cdd.2015.140. Epub 2016 Jan 15.

9.

TXNIP maintains the hematopoietic cell pool by switching the function of p53 under oxidative stress.

Jung H, Kim MJ, Kim DO, Kim WS, Yoon SJ, Park YJ, Yoon SR, Kim TD, Suh HW, Yun S, Min JK, Lee HG, Lee YH, Na HJ, Lee DC, Kim HC, Choi I.

Cell Metab. 2013 Jul 2;18(1):75-85. doi: 10.1016/j.cmet.2013.06.002.

10.

Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation.

Hoggatt J, Singh P, Sampath J, Pelus LM.

Blood. 2009 May 28;113(22):5444-55. doi: 10.1182/blood-2009-01-201335. Epub 2009 Mar 26.

11.

Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal.

Pietras EM, Mirantes-Barbeito C, Fong S, Loeffler D, Kovtonyuk LV, Zhang S, Lakshminarasimhan R, Chin CP, Techner JM, Will B, Nerlov C, Steidl U, Manz MG, Schroeder T, Passegué E.

Nat Cell Biol. 2016 Jun;18(6):607-18. doi: 10.1038/ncb3346. Epub 2016 Apr 25.

12.

IGF binding protein 2 supports the survival and cycling of hematopoietic stem cells.

Huynh H, Zheng J, Umikawa M, Zhang C, Silvany R, Iizuka S, Holzenberger M, Zhang W, Zhang CC.

Blood. 2011 Sep 22;118(12):3236-43. doi: 10.1182/blood-2011-01-331876. Epub 2011 Aug 5.

13.

Hematopoietic stem cells lacking Ott1 display aspects associated with aging and are unable to maintain quiescence during proliferative stress.

Xiao N, Jani K, Morgan K, Okabe R, Cullen DE, Jesneck JL, Raffel GD.

Blood. 2012 May 24;119(21):4898-907. doi: 10.1182/blood-2012-01-403089. Epub 2012 Apr 6.

14.

Dasatinib promotes the activation of quiescent hematopoietic stem cells in mice.

Duyvestyn JM, Taylor SJ, Dagger SA, Langdon WY.

Exp Hematol. 2016 May;44(5):410-421.e5. doi: 10.1016/j.exphem.2016.02.008. Epub 2016 Feb 26.

PMID:
26921649
15.

The role of Skp2 in hematopoietic stem cell quiescence, pool size, and self-renewal.

Wang J, Han F, Wu J, Lee SW, Chan CH, Wu CY, Yang WL, Gao Y, Zhang X, Jeong YS, Moten A, Samaniego F, Huang P, Liu Q, Zeng YX, Lin HK.

Blood. 2011 Nov 17;118(20):5429-38. doi: 10.1182/blood-2010-10-312785. Epub 2011 Sep 19.

16.

Thioredoxin-interacting protein regulates hematopoietic stem cell quiescence and mobilization under stress conditions.

Jeong M, Piao ZH, Kim MS, Lee SH, Yun S, Sun HN, Yoon SR, Chung JW, Kim TD, Jeon JH, Lee J, Kim HN, Choi JY, Choi I.

J Immunol. 2009 Aug 15;183(4):2495-505. doi: 10.4049/jimmunol.0804221. Epub 2009 Jul 22.

17.

Regulation of murine hematopoietic stem cell quiescence by Dmtf1.

Kobayashi M, Srour EF.

Blood. 2011 Dec 15;118(25):6562-71. doi: 10.1182/blood-2011-05-349084. Epub 2011 Oct 28.

18.

Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates.

Passegué E, Wagers AJ, Giuriato S, Anderson WC, Weissman IL.

J Exp Med. 2005 Dec 5;202(11):1599-611.

19.

TIMP-3 recruits quiescent hematopoietic stem cells into active cell cycle and expands multipotent progenitor pool.

Nakajima H, Ito M, Smookler DS, Shibata F, Fukuchi Y, Morikawa Y, Ikeda Y, Arai F, Suda T, Khokha R, Kitamura T.

Blood. 2010 Nov 25;116(22):4474-82. doi: 10.1182/blood-2010-01-266528. Epub 2010 Aug 26.

20.

CXCR4 is required for the quiescence of primitive hematopoietic cells.

Nie Y, Han YC, Zou YR.

J Exp Med. 2008 Apr 14;205(4):777-83. doi: 10.1084/jem.20072513. Epub 2008 Mar 31.

Supplemental Content

Support Center